By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


SEARCH JOBS



Key Statistics


Email:
Ownership: Public

Web Site: Supernus Pharmaceuticals
Employees:
Symbol: SUPN
 



Industry
Pharmaceutical






Company News
Georges Gemayel, Ph.D., Joins Supernus Pharmaceuticals (SUPN) Board Of Directors 3/24/2015 10:19:59 AM
Supernus Pharmaceuticals (SUPN) Announces Fourth Quarter And Full Year 2014 Results 3/11/2015 7:41:52 AM
Supernus Pharmaceuticals (SUPN) To Present At March Cowen and Company Conference 2/19/2015 8:45:23 AM
Supernus Pharmaceuticals (SUPN) To Host Fourth Quarter And Full Year 2014 Earnings Conference Call 2/18/2015 7:45:47 AM
Supernus Pharmaceuticals (SUPN) Sues TWi Pharmaceuticals, Inc. For Infringement Of Oxtellar XR® Patents 1/22/2015 8:14:41 AM
Supernus Pharmaceuticals (SUPN) Sues Par Pharmaceutical Companies, Inc. (PRX) For Infringement Of Trokendi XR® Patents 1/19/2015 7:05:30 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Oxtellar XR® 12/10/2014 7:06:46 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Trokendi XR® 12/9/2014 10:54:54 AM
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR 11/25/2014 7:18:12 AM
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R) 11/24/2014 1:12:06 PM
123456789
//-->